Abdominal aortic aneurysm

Revision as of 17:59, 14 July 2011 by Anjelica Montemayor (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Abdominal Aortic Aneurysm Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Abdominal Aortic Aneurysm from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Case Studies

Case #1

Abdominal aortic aneurysm On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Abdominal aortic aneurysm

CDC on Abdominal aortic aneurysm

Abdominal aortic aneurysm in the news

Blogs on Abdominal aortic aneurysm

Directions to Hospitals Treating Abdominal aortic aneurysm

Risk calculators and risk factors for Abdominal aortic aneurysm

WikiDoc Resources for Abdominal aortic aneurysm

Articles

Most recent articles on Abdominal aortic aneurysm

Most cited articles on Abdominal aortic aneurysm

Review articles on Abdominal aortic aneurysm

Articles on Abdominal aortic aneurysm in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Abdominal aortic aneurysm

Images of Abdominal aortic aneurysm

Photos of Abdominal aortic aneurysm

Podcasts & MP3s on Abdominal aortic aneurysm

Videos on Abdominal aortic aneurysm

Evidence Based Medicine

Cochrane Collaboration on Abdominal aortic aneurysm

Bandolier on Abdominal aortic aneurysm

TRIP on Abdominal aortic aneurysm

Clinical Trials

Ongoing Trials on Abdominal aortic aneurysm at Clinical Trials.gov

Trial results on Abdominal aortic aneurysm

Clinical Trials on Abdominal aortic aneurysm at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Abdominal aortic aneurysm

NICE Guidance on Abdominal aortic aneurysm

NHS PRODIGY Guidance

FDA on Abdominal aortic aneurysm

CDC on Abdominal aortic aneurysm

Books

Books on Abdominal aortic aneurysm

News

Abdominal aortic aneurysm in the news

Be alerted to news on Abdominal aortic aneurysm

News trends on Abdominal aortic aneurysm

Commentary

Blogs on Abdominal aortic aneurysm

Definitions

Definitions of Abdominal aortic aneurysm

Patient Resources / Community

Patient resources on Abdominal aortic aneurysm

Discussion groups on Abdominal aortic aneurysm

Patient Handouts on Abdominal aortic aneurysm

Directions to Hospitals Treating Abdominal aortic aneurysm

Risk calculators and risk factors for Abdominal aortic aneurysm

Healthcare Provider Resources

Symptoms of Abdominal aortic aneurysm

Causes & Risk Factors for Abdominal aortic aneurysm

Diagnostic studies for Abdominal aortic aneurysm

Treatment of Abdominal aortic aneurysm

Continuing Medical Education (CME)

CME Programs on Abdominal aortic aneurysm

International

Abdominal aortic aneurysm en Espanol

Abdominal aortic aneurysm en Francais

Business

Abdominal aortic aneurysm in the Marketplace

Patents on Abdominal aortic aneurysm

Experimental / Informatics

List of terms related to Abdominal aortic aneurysm

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [3] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Epidemiology and Demographics

Risk Factors

Diagnostic Findings

Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology






Labeled images shown below are courtesy of Radswiki and copylefted.





Screening

Pathophysiology & Etiology

Diagnosis

AAAs are commonly divided according to their size and symptomatology. An aneurysm is usually considered to be present if the measured outer aortic diameter is over 3 cm (normal diameter of aorta is around 2 cm). The natural history is of increasing diameter over time, followed eventually by the development of symptoms (usually rupture). If the outer diameter exceeds 5 cm, the aneurysm is considered to be large. For aneurysms under 5 cm, the risk of rupture is low, so that the risks of surgery usually outweigh the risk of rupture. Aneurysms less than 5cm are therefore usually kept under surveillance until such time as they become large enough to warrant repair, or develop symptoms.[1][2] The vast majority of aneurysms are asymptomatic. The risk of rupture is high in a symptomatic aneurysm, which is therefore considered an indication for surgery. Possible symptoms include low back pain, flank pain, abdominal pain, groin pain or pulsating abdominal mass.[3] The complications include rupture, peripheral embolisation, acute aortic occlusion, aortocaval or aortoduodenal fistulae. On physical examination, a palpable abdominal mass can be noted. Bruits can be present in case of renal or visceral arterial stenosis.[4]

CT image showing an abdominal aortic aneurysm.

As most of the AAAs are asymptomatic, their presence is usually revealed during an abdominal examination for another reason - the most common being abdominal ultrasonography. A physician may also detect the presence of an AAA by abdominal palpation. Ultrasonography provides the initial assessment of the size and extent of the aneurysm, and is the usual modality for surveillance. Preoperative examinations include CT, MRI and special modes thereof, like CT/MR angiography. Angiography may be useful also, as an additional method of measurement for the planning of endoluminal repair. Note that an aneurysmal aorta may appear normal on angiogram, due to thrombus within the sac.

  • Many AAAs are detected incidentally during cardiac catheterizations, computed tomography (CT), or magnetic resonance imaging (MRI) performed for unrelated reasons.
  • Up to 50% of AAAs can be recognized on plain roentgenograms as a calcified aneurysmal wall.

History and Symptoms

  • Most AAAs are asymptomatic and expand silently.
  • Spontaneous abdominal pain in a patient with a pulsatile epigastric mass or a known AAA may signal rupture into the retroperitoneum or leakage within the aneurysm wall
    • This could lead to rapid expansion or imminent rupture.
  • Peripheral embolization to the lower extremities (common in popliteal artery aneurysms) is rare with AAAs.
    • Rarely in larger or unstable aneurysms, disseminated intravascular coagulopathy may develop.

Physical Examination

  • The physical examination may miss a substantial number of asymptomatic AAAs
  • The abdominal aorta should be checked during regular physical examinations because it is easy to do and may detect a life-threatening aneurysm.
  • The sensitivity of physical examination increases with the size of the aneurysm:
    • 29-61% for AAAs 3.0-3.9 cm in diameter
    • 76-82% for those AAAs 5.0 cm or larger
  • Generally, it is easier to detect a pulsatile mass in thin patients and those who do not have tense abdomens.
  • Contrary to popular belief, gentle palpation of AAAs is safe, and does not precipitate rupture.

Differential Diagnosis

Conditions Associated with AAAs

Contrast CT

  • Provides detailed anatomic information and is valuable in planning AAA repair
  • The disadvantages include:
    • Nephrotoxicity
    • Cost
    • Exposure to radiation
    • Suboptimal visualization of the origins of the aortic branch vessels
    • Occasionally, inaccurate localizing of the aneurysmal neck

Magnetic Resonance Angiography (MRA)

  • Does not require nephrotoxic contrast
  • Less accurate than thin-slice CT
  • Costly, and is not as readily available as contrast CT and ultrasonography

Echocardiography or Ultrasound

  • Ultrasonography has a sensitivity close to 100%
    • Well accepted by patients
    • The preferred method for detecting and following the progression of AAAs
    • Able to show the dimensions of the abdominal aorta and other relevant findings:
      • Mural thrombus
      • Iliac artery aneurysms
    • Patients should fast before examination to optimize image quality.

Contrast Aortography

  • Performed before surgery in patients suspected of having the following:
    • Suprapenal or juxtarenal aneurysms
    • Renovascular hypertension
    • Ischemic nephropathy
    • Mesenteric ischemia
    • Associated iliofemoral arterial occlusive disease
  • Should not be used to assess the size of an AAA because the common presence of mural thrombus often leads to diameter underestimation

Treatment

Acute Pharmacotherapies

  • Antimetalloproteases such as doxycycline and roxithromycin may halt aneurysm expansion
  • Similarly, non-steriod anti inflammatory drugs have shown to be beneficial in small studies
  • Beta blockers have numerous benefits in patients with cardiovascular disease
    • Reduce aortic complications in patients with Marfan syndrome
    • Slow progression of AAAs in hypertensive patients
    • In the absence of other indications for beta blockers, the evidence is insufficient to recommend using them routinely for the sole purpose of slowing atherosclerotic aneurysm growth

Surgery and Device Based Therapy

Indications for Surgery

The treatment options for asymptomatic AAA are immediate repair, surveillance with a view to eventual repair, and conservative. There are currently two modes of repair available for an AAA: open aneurysm repair (OR), and endovascular aneurysm repair (EVAR).

  • Conservative treatment is indicated in patients where repair carries a high risk of mortality and also in patients where repair is unlikely to improve life expectancy. The two mainstays of the conservative treatment are smoking cessation and blood pressure control.
  • Surveillance is indicated in small aneurysms, where the risk of repair exceeds the risk of rupture. As an AAA grows in diameter the risk of rupture increases. Although some controversy exists around the world, most vascular surgeons would not consider repair until the aneurysm reached a diameter of 5cm. The threshold for repair varies slightly from individual to individual, depending on the balance of risks and benefits when considering repair versus ongoing surveillance. The size of an individual's native aorta may influence this, along with the presence of comorbitities that increase operative risk or decrease life expectancy.
  • Open repair (operation) is indicated in young patients as an elective procedure, or in growing or large, symptomatic or ruptured aneurysms. Open repair has been the mainstay of intervention from the 1950's until recently.
  • Endovascular repair first became practical in the 1990's and although it is now an established alternative to open repair, its role is yet to be clearly defined. It is generally indicated in older, high-risk patients or patients unfit for open repair. However, endovascular repair is feasible for only a proportion of AAA's, depending on the morphology of the aneurysm. The main advantage over open repair is that the peri-operative period has less impact on the patient (less time in intensive care, less time in hospital overall, earlier return to normal activity). Disadvantages of endovascular repair include a requirement for more frequent ongoing hospital reviews, and a higher chance of further procedures being required. According to the latest studies, the EVAR procedure doesn't offer any overall survival benefit.[5] Regarding unruptured aneurysms, EVAR is associated with lower operative mortality than open repair but unknown long-term mortality[6]

Pre-Operative Assessment

  • The ADAM trial suggested that the "biological age," as reflected by the condition of the vital organs such as the lungs, kidneys, heart was more important than the chronological age as a determinant of operative outcome. ADAMref4
  • Patients with poor renal and pulmonary function have worse operative outcomes
    • Chronic obstructive pulmonary disease
    • Elevated creatinine concentrations
    • Electrocardiographic evidence of ischemia
  • Aortic factors implicated in postoperative morbidity and mortality include:
    • Extensive atheromatous disease
    • Mural calcification
    • Thrombosis
    • Juxtarenal extension of aneurysm
    • Inflammatory aortic aneurysms
    • The increased risk resulted from:
      • Longer suprapenal clamping time
      • Need for complex dissection
      • Increased hemodynamic stresses

Pathological Findings

Images shown below are courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology























Videos on Abdominal Aortic Aneurysm

<youtube v=Sb1bM8MnpRk/>


<youtube v=9XPPbWsrtRA/>


<youtube v=ovGI2fYc_U8/>


References

  1. O'Connor RE: Aneurysm, Abdominal, on emedicine, accessed June 23, 2006.
  2. Rutherford RB. Randomized EVAR Trials and Advent of Level I Evidence: A Paradigm Shift in Management of Large Abdominal Aortic Aneurysms? Semin Vasc Surg 2006; 19:69-74. PMID 16782510
  3. Lederle FA, Kane RL, MacDonald R, Wilt TJ (2007). "Systematic review: repair of unruptured abdominal aortic aneurysm". Ann. Intern. Med. 146 (10): 735–41. PMID 17502634.

Acknowledgements

The content on this page was first contributed by: C. Michael Gibson M.S., M.D.


Template:SIB


Template:WikiDoc Sources